Life Sciences / Companies

Ridgeback Capital

Ridgeback Capital is an actively managed private investment company, founded in 2006 by Wayne Holman, MD, that specializes in securities trading and long-term private investment with a focused emphasis on investing in life science and biopharma companies. The firm provides patient capital to private and public healthcare companies and states a goal of supporting innovators developing life-saving and life-changing technologies.

Ridgeback Capital

New York, New York, United States, North America

Services

Actively managed securities trading

Operates an actively managed securities trading platform as part of the firm's investment activities.

Long-term private investment (patient capital)

Provides long-term private investment capital intended to support the multi-year development timelines of healthcare and life-science companies.

Capital investment in private and public life-science companies

Makes investments in both private and public companies focused on healthcare and life-science technologies.

Active investment support

States that long-term private investment capital gives the firm flexibility to support innovators and help fund development and commercialization efforts.

Portfolio

Adaptimmune

Listed as a select investment on Ridgeback Capital website.

#Biopharma / Life Sciences

Cellectis

Listed as a select investment on Ridgeback Capital website.

#Biopharma / Life Sciences

FibroGen

Listed as a select investment on Ridgeback Capital website.

#Biopharma / Life Sciences

MacroGenics

Listed as a select investment on Ridgeback Capital website.

#Biopharma / Life Sciences

Sangamo

Listed as a select investment on Ridgeback Capital website.

#Biopharma / Life Sciences

Ironwood Pharmaceuticals

Listed as a select investment on Ridgeback Capital website.

#Biopharma / Life Sciences

View All Portfolio Items

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.